Andrew Yang, MD
Vascular Surgery · Columbus, OHNPI 1700205986
Payments from drug & device makers
What this record shows
This record is dominated by other: $10,042 of the $12,532 with a category attached, or 80.1%. Angiodynamics, Inc. accounts for 80.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $10,186 and has fallen 96.0% since, to $407 in 2025.
Across 28 payments — averaging $447.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$10K
- Endologix LLC$898
- Medtronic$590
- W. L. Gore & Associates, Inc.$359
- Penumbra, Inc.$338
- Inari Medical, Inc.$144
- plus $117 from 5 others
What the payments were for
- Food & beverage$2,01516%
- Education$4764%
- Other$10,04280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 4 | $10,087 |
| Endologix LLC | 8 | $898 |
| Medtronic(2 entities) | 3 | $590 |
| W. L. Gore & Associates, Inc. | 3 | $359 |
| Penumbra, Inc. | 3 | $338 |
| Inari Medical, Inc. | 1 | $144 |
| Davol Inc. | 1 | $30 |
| AbbVie | 2 | $24 |
| Boston Scientific | 1 | $23 |
| Bioventus LLC | 1 | $23 |
| CSL Behring | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,532 in reported general payments places this provider in the 80th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $19,307 |
| BrilintaTicagrelor | 12 | $6,779 |
| ClopidogrelClopidogrel Bisulfate | 79 | $611 |
| Atorvastatin Calcium | 41 | $379 |
| Gabapentin | 29 | $333 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $55 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $48 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Columbus
- Simon FraserColumbus$25K
- Kapil GopalColumbus$23K
- Charles PugarColumbus$19K
- David EpsteinColumbus$11K
- Patrick MuckCincinnati$650K
- Sean LydenCleveland$561K
- Brian KuhnCincinnati$184K
- Vikram RaoWilloughby$137K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.